Resumen de acción ELV
Elevance Health, Inc. junto con sus filiales, opera como empresa de prestaciones sanitarias en Estados Unidos.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 1/6 |
| Resultados anteriores | 3/6 |
| Salud financiera | 4/6 |
| Dividendos | 3/6 |
Recompensas
Análisis de riesgos
Competidores de Elevance Health, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$504.72 |
| Máximo en 52 semanas | US$555.36 |
| Mínimo de 52 semanas | US$431.38 |
| Beta | 0.85 |
| 11 mes Cambio | -4.28% |
| Variación en 3 meses | -5.02% |
| Cambio de 1 año | 6.09% |
| 3Variación en 3 años | 31.33% |
| Variación en 5 años | 71.70% |
| Variación desde la OPV | 2,368.07% |
Noticias y actualizaciones recientes
Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11
Recent updates
Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?
Nov 16Elevance Health to acquire speciality pharmacy from CarepathRx
Nov 09Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price
Nov 02Elevance Health declares $1.28 dividend
Oct 19Rentabilidad de los accionistas
| ELV | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | -5.5% | 5.3% | -0.7% |
| 1Y | 6.1% | 4.3% | 20.2% |
Rentabilidad vs. Industria: ELV superó a la industria US Healthcare, que obtuvo un rendimiento del 4.3% el año pasado.
Rentabilidad vs. Mercado: ELV obtuvo unos resultados inferiores a los del mercado US, que fueron del 22.6% el año pasado.
Volatilidad de los precios
| ELV volatility | |
|---|---|
| ELV Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: ELV no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ELV (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc. junto con sus filiales, opera como empresa de prestaciones sanitarias en Estados Unidos. La empresa opera a través de cuatro segmentos: Health Benefits, CarelonRx, Carelon Services y Corporate & Other. Ofrece una variedad de planes de salud y servicios a los miembros del programa; productos de salud; una gama de servicios administrativos de atención gestionada basados en honorarios; y productos y servicios de seguros especializados y de otro tipo, tales como stop loss, dental, visión, vida, discapacidad y beneficios de seguros de salud complementarios.
Resumen de fundamentos de Elevance Health, Inc.
| Estadísticas fundamentales de ELV | |
|---|---|
| Capitalización bursátil | US$120.80b |
| Beneficios(TTM) | US$6.69b |
| Ingresos (TTM) | US$171.72b |
17.5x
Ratio precio-beneficio (PE)0.7x
Ratio precio-ventas (PS)¿Está ELV sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ELV | |
|---|---|
| Ingresos | US$171.72b |
| Coste de los ingresos | US$123.06b |
| Beneficio bruto | US$48.66b |
| Otros gastos | US$41.97b |
| Beneficios | US$6.69b |
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 28.85 |
| Margen bruto | 28.34% |
| Margen de beneficio neto | 3.90% |
| Ratio deuda/patrimonio | 65.5% |
¿Cómo se ha desempeñado ELV a largo plazo?
Ver rendimiento histórico y comparativa